Empromptu's "golden pipeline" approach tackles the last-mile data problem in agentic AI by integrating normalization directly into the application workflow — replacing weeks of manual data prep with ...

Outside of tightly controlled environments, most robotic systems still struggle with reliability, generalization and cost. The gap between what we can demonstrate and what we can operate at scale ...

This one simple shift is changing how companies turn data into decisions—and why most leaders are still missing it.

Sanger sequencing is the unsung workhorse of molecular biology, one whose value has long been undermined by the tedious nature of processing its data. Converting files of raw sequencing data into a ...

Data is arguably the most valuable asset for today’s businesses. This means it’s vital that people across the organization are able to work with data and extract insights – insights that (hopefully) ...

‘There’s a lot of hype around AI. But let’s face it, most companies haven’t really realized much of a return on their AI investments to date,’ said Qlik CEO Mike Capone. One thing’s for sure about AI: ...

It’s no longer how good your model is, it’s how good your data is. Why privacy-preserving synthetic data is key to scaling AI. The potential of generative AI has captivated both businesses and ...

Healthcare data accounts for 30% of the world’s data, and that proportion will jump to 36% by next year. Yet healthcare leaders say just 57% of their data is used to make intelligent business ...